The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Pfizer; Sanofi
Research Funding - 23andMe (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst); SignalChem (Inst); Treadwell Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer.
 
Valsamo Anagnostou
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Delfi Diagnostics (Inst); Personal Genome Diagnostics (Inst)
 
Sara Moore
Honoraria - AstraZeneca; Bristol-Meyers Squibb
Research Funding - AstraZeneca (Inst)
 
Cheryl Ho
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Jazz Pharmaceuticals; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche; Sanofi; Sterimax
Research Funding - AstraZeneca (Inst); Roche Canada (Inst)
 
Garth Andrew Nicholas
No Relationships to Disclose
 
Rosalyn A. Juergens
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Jazz Pharmaceuticals; Merck Sharp & Dohme; Mirati Therapeutics; Novartis Canada Pharmaceuticals Inc; Pfizer; Roche Canada; Sanofi; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Fusion Pharmaceuticals; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche Canada; Sanofi/Regeneron; Takeda
Research Funding - Alkermes (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bold Therapeutics (Inst); Bristol-Myers Squibb (Inst); Fusion Pharmaceuticals (Inst); Janssen (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst); mirai (Inst); Novartis (Inst); Pfizer (Inst)
 
Adrian G. Sacher
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Bridgebio (Inst); CRISPR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Hotspot Therapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly Loxo (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Andrea S. Fung
Research Funding - AstraZeneca (Inst)
 
Paul Wheatley-Price
Honoraria - AstraZeneca Canada; Bayer; Merck; Novartis; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Novartis; Pfizer; Roche Canada; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche Canada (Inst)
 
Scott Laurie
No Relationships to Disclose
 
Benjamin Philip Levy
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Guardant Health; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Novartis; Novocure; Pfizer; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Turning Point Therapeutics (Inst)
 
Julie R. Brahmer
Honoraria - Janssen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech; GlaxoSmithKline; Incyte; Merck; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); RAPT Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Other Relationship - Bristol-Myers Squibb; Merck; Regeneron
 
Egor Avrutin
No Relationships to Disclose
 
Liting Zhu
No Relationships to Disclose
 
Mark Sausen
Employment - LabCorp; Personal Genome Diagnostics
Stock and Other Ownership Interests - LabCorp
Patents, Royalties, Other Intellectual Property - Patents
 
Penelope Ann Bradbury
(OPTIONAL) Uncompensated Relationships - Abbvie; Bristol-Myers Squibb; Merck; Mirati Therapeutics
 
Jill O'Donnell-Tormey
Leadership - Coherus Biosciences
Stock and Other Ownership Interests - Coherus Biosciences
Travel, Accommodations, Expenses - Coherus Biosciences
 
Pierre-Olivier Gaudreau
Research Funding - AstraZeneca (Inst); BioAtla (Inst); Novartis (Inst); Repare Therapeutics (Inst); Treadwell Therapeutics (Inst)
 
Keyue Ding
No Relationships to Disclose
 
Janet Ellen Dancey
Leadership - 3Ci
Honoraria - 3Ci
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)